These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1273067)

  • 1. [Thrombocytic complications in a patient with an inhibitor against the contact factor].
    Papaian LP; Litmanovich KIu
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):56-9. PubMed ID: 1273067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemorrhage after tonsillectomy in a patient with PTA and Hageman factor deficiency: clinico-therapeutic considerations].
    Lecco V; Orlandi GF
    Ann Laringol Otol Rinol Faringol; 1968; 67(2):275-80. PubMed ID: 5757319
    [No Abstract]   [Full Text] [Related]  

  • 3. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

  • 4. Naturally occurring anticoagulants: a case report.
    Ross SA
    N Z Med J; 1968 Mar; 67(430):411-3. PubMed ID: 4968117
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Inhibition of blood coagulation factor XI-XII by monoclonal IgM.
    Valentin IR; Rimon A; Lahav M
    Isr J Med Sci; 1975 Dec; 11(12):1392. PubMed ID: 815201
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
    Scott CF; Carrell RW; Glaser CB; Lewis JH; Colman RW
    Trans Assoc Am Physicians; 1985; 98():344-51. PubMed ID: 3879844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of factor XII deficiency with prolonged bleeding time].
    Sroczyński J; Kossmann S; Wegiel A
    Acta Haematol Pol; 1971; 2(3):239-42. PubMed ID: 5161839
    [No Abstract]   [Full Text] [Related]  

  • 8. The lupus inhibitor: a study of its heterogeneity.
    Coots MC; Miller MA; Glueck HI
    Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation defects in acute promyelocytic leukemia.
    Rand JJ; Moloney WD; Sise HS
    Arch Intern Med; 1969 Jan; 123(1):39-47. PubMed ID: 5248747
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Salicylic acid derivatives used as anticoagulants].
    Bruhn HD
    Verh Dtsch Ges Inn Med; 1971; 77():1035-7. PubMed ID: 5155959
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of alkaline and acid phosphatases on clotting: Evidence that alkaline phosphatase enhances activation of factor IX by SF, and that acid phosphatase enhances plasmatic anti-SF.
    Iatridis PG; Ferguson JH
    Thromb Diath Haemorrh; 1966 May; 15(3):365-80. PubMed ID: 5989024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and experimental studies on the contact factor. I. Contact factor activity in various dieases].
    Ito M
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1142-54. PubMed ID: 5753795
    [No Abstract]   [Full Text] [Related]  

  • 14. Method of purification and properties of anti-XIa (inhibitor of the contact product).
    Niemetz J; Nossel HL
    Thromb Diath Haemorrh; 1967 May; 17(3-4):335-48. PubMed ID: 5589293
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating anticoagulant against factor XI in psoriasis.
    Rustgi RN; LaDuca FM; Tourbaf KD
    J Med; 1982; 13(4):289-301. PubMed ID: 6957528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of surface-sensitive coagulation factors XII and XI in intravasal coagulation].
    Müller-Berghaus G; Ehlers E; Käufer P
    Verh Dtsch Ges Inn Med; 1974; 80():1458-60. PubMed ID: 4454455
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of hemostasis in dysthyroidism].
    Klein M; Barbé F; Kaminsky P; Duc M
    Pathol Biol (Paris); 1993 Mar; 41(3):268-75. PubMed ID: 8332397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reactions initiating blood coagulation].
    Zubairov DM; Baĭkeev RF
    Ukr Biokhim Zh (1978); 1983; 55(3):281-4. PubMed ID: 6553424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.